S. Song

Determinants of drug delivery and transport to solid tumors.

M. Wientjes, J. L. Au, S. Jang, 2001, Journal of controlled release : official journal of the Controlled Release Society.

Thiacremonone Augments Chemotherapeutic Agent–Induced Growth Inhibition in Human Colon Cancer Cells through Inactivation of Nuclear Factor-κB

D. Yoon, J. Hong, H. Jeong, 2009, Molecular Cancer Research.

Effect of PSC 833, a P-glycoprotein modulator, on the disposition of vincristine and digoxin in rats.

Y. Sugiyama, H. Suzuki, R. Kawai, 1999, Drug metabolism and disposition: the biological fate of chemicals.

Dose-dependent effects of PSC 833 on its tissue distribution and on the biliary excretion of endogenous substrates in rats.

Y. Sugiyama, H. Suzuki, C. Tanaka, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.

J. Au, M. Wientjes, J. L. Au, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Nontoxic doses of suramin enhance activity of paclitaxel against lung metastases.

M. Wientjes, J. L. Au, S. Song, 2001, Cancer research.

Modulation of the tumor disposition of vinca alkaloids by PSC 833 in vitro and in vivo.

Y. Sugiyama, T. Terasaki, H. Suzuki, 1998, The Journal of pharmacology and experimental therapeutics.

Bortezomib-Cyclophosphamide-Dexamethasone for Relapsing Multiple Myeloma

Michael L. Wang, Jialei Wang, J. Hou, 2012, American journal of clinical oncology.